Treatment of Psoriasis with Biologics in Cooperation with Regional Medical Institutions

Abstract

　Psoriasis is a chronic inflammatory disease that greatly impairs the quality of life. In recent years, biologics have been continuously developed based on analysis of the pathomechanism. As a result, there are increasing cases in which high therapeutic effects are obtained even in cases that had been refractory. However, their use has not spread sufficiently because greater attention must be paid to adverse events with biologics compared with conventional therapies. Based on the chronic course of psoriasis, it is important that dermatology clinics and local base hospitals collaborate for the medical care of psoriasis.